Announcements Trials

Browse Landscape

Phase

Phase 3 2 Phase NA 1 Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 549 Carcinoma, Non-Small-Cell Lung 506 Prostatic Neoplasms 335 Colorectal Neoplasms 268 Multiple Myeloma 267 Neoplasms 259 Leukemia, Myeloid, Acute 218 Squamous Cell Carcinoma of Head and Neck 213 Lung Neoplasms 206 Neoplasm Metastasis 204 Carcinoma, Hepatocellular 197 Triple Negative Breast Neoplasms 172 Melanoma 172 Pancreatic Neoplasms 171 Recurrence 153 Ovarian Neoplasms 151 Lymphoma 140 Sarcoma 132 Glioblastoma 132 Brain Neoplasms 132 Head and Neck Neoplasms 126 Carcinoma, Renal Cell 126 Leukemia, Lymphocytic, Chronic, B-Cell 125 Stomach Neoplasms 123 Lymphoma, Large B-Cell, Diffuse 123 Rectal Neoplasms 106 Precursor Cell Lymphoblastic Leukemia-Lymphoma 104 Uterine Cervical Neoplasms 101 Urinary Bladder Neoplasms 101 Myelodysplastic Syndromes 101

Interventions

Tretinoin 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Breast Neoplasm Female × 1 year × Clear all

NCT04113863 2025-12-18

ATRA

Mario Negri Institute for Pharmacological Research

Phase 2 Terminated

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡